Clinical Trials in Boston

Showing 9261-9280 of 13,548 trials

CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study

NCT02996032

This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.

Heart Failure

Boston Medical Center187 participantsStarted Nov 2016

Boston, Massachusetts, United States

COMPLETEDPhase 1/2< 1 mile

Free Fatty Acids and Vascular Function in Subjects With Diabetes

NCT00153179

This study will test the hypothesis that reduction in release of free fatty acids from adipocytes will restore insulin-mediated endothelium-dependent vasodilation and skeletal muscle glucose metabolism in subject with type 2 diabetes.

Type 2 Diabetes Mellitus

Brigham and Women's Hospital40 participantsStarted Sep 2005

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

NCT02184442

The purpose of this study is to determine the safety and effectiveness of the SAPIEN XT™ THV with the associated delivery system for inoperable patients with severe symptomatic native aortic stenosis.

SevereSymptomaticCalcific Aortic Stenosis

Edwards Lifesciences560 participantsStarted Mar 2011

Little Rock, Arkansas, United States • La Jolla, California, United States • La Jolla, California, United States +50 more locations

CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study

Free Fatty Acids and Vascular Function in Subjects With Diabetes

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

Find Trials by Condition in Boston

Phase II Combination Steroid and Anti-VEGF for Persistent DME

Procedures for Improving the Mucosa Around Implants

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Assessing Tobacco Product Choice When the Cost of Menthol Cigarettes Increases

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate